Tandem Diabetes Care TNDM Investment Income Net Amortization Of Discount And Premium
Investment Income Net Amortization Of Discount And Premium at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's investment income net amortization of discount and premium.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's investment income net amortization of discount and premium?
- Tandem Diabetes Care (TNDM) reported investment income net amortization of discount and premium of $747K in Q1 2026.
- How has Tandem Diabetes Care's investment income net amortization of discount and premium changed year-over-year?
- Tandem Diabetes Care's investment income net amortization of discount and premium decreased by 34.9% year-over-year, from $1.15M to $747K.
- What is the long-term trend for Tandem Diabetes Care's investment income net amortization of discount and premium?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's investment income net amortization of discount and premium has grown at a 80.0% compound annual growth rate (CAGR), from -$365K to $3.83M.
- What does investment income net amortization of discount and premium mean?
- This metric captures the net impact of interest income earned on cash equivalents and short-term investments, adjusted for the amortization of premiums or discounts on those securities. It reflects the yield generated from the company's treasury management activities. A consistent positive value indicates effective utilization of excess liquidity to generate supplemental non-operating income.